NO20020254L - Nye karboksylsyrederivater med 5,6-substituert pyrimidinring, fremstilling og anvendelse derav som endotelinreseptor-antagonister - Google Patents

Nye karboksylsyrederivater med 5,6-substituert pyrimidinring, fremstilling og anvendelse derav som endotelinreseptor-antagonister

Info

Publication number
NO20020254L
NO20020254L NO20020254A NO20020254A NO20020254L NO 20020254 L NO20020254 L NO 20020254L NO 20020254 A NO20020254 A NO 20020254A NO 20020254 A NO20020254 A NO 20020254A NO 20020254 L NO20020254 L NO 20020254L
Authority
NO
Norway
Prior art keywords
preparation
carboxylic acid
acid derivatives
receptor antagonists
pyrimidine ring
Prior art date
Application number
NO20020254A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020254D0 (no
Inventor
Wilhelm Amberg
Georg Kettschau
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20020254D0 publication Critical patent/NO20020254D0/no
Publication of NO20020254L publication Critical patent/NO20020254L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
NO20020254A 1999-07-20 2002-01-17 Nye karboksylsyrederivater med 5,6-substituert pyrimidinring, fremstilling og anvendelse derav som endotelinreseptor-antagonister NO20020254L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19933164A DE19933164A1 (de) 1999-07-20 1999-07-20 Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten
PCT/EP2000/006293 WO2001005771A1 (de) 1999-07-20 2000-07-05 Neue carbonsäurederivate mit 5,6 substituiertem pyrimidinring, ihre herstellung und verwendung als endothelin rezeptorantagonisten

Publications (2)

Publication Number Publication Date
NO20020254D0 NO20020254D0 (no) 2002-01-17
NO20020254L true NO20020254L (no) 2002-02-20

Family

ID=7914884

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020254A NO20020254L (no) 1999-07-20 2002-01-17 Nye karboksylsyrederivater med 5,6-substituert pyrimidinring, fremstilling og anvendelse derav som endotelinreseptor-antagonister

Country Status (21)

Country Link
EP (1) EP1196394A1 (cs)
JP (1) JP2003505377A (cs)
KR (1) KR20020019550A (cs)
CN (1) CN1367778A (cs)
AR (1) AR030026A1 (cs)
AU (1) AU6561500A (cs)
BG (1) BG106321A (cs)
BR (1) BR0012592A (cs)
CA (1) CA2379545A1 (cs)
CZ (1) CZ2002190A3 (cs)
DE (1) DE19933164A1 (cs)
HU (1) HUP0202646A3 (cs)
IL (1) IL147666A0 (cs)
MX (1) MXPA02000616A (cs)
NO (1) NO20020254L (cs)
PL (1) PL353165A1 (cs)
SK (1) SK772002A3 (cs)
TR (1) TR200200622T2 (cs)
TW (1) TW555749B (cs)
WO (1) WO2001005771A1 (cs)
ZA (1) ZA200200333B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962832B2 (en) * 2009-07-10 2015-02-24 Cadila Healthcare Limited Process for the preparation of ambrisentan and novel intermediates thereof
WO2011114338A1 (en) 2010-03-15 2011-09-22 Natco Pharma Limited A process for the preparation of highly pure ambrisentan

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636046A1 (de) * 1996-09-05 1998-03-12 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten
CN1278251A (zh) * 1997-10-31 2000-12-27 Basf公司 新的带酰胺侧链的羧酸衍生物及其制备方法和作为内皮素受体拮抗剂的用途

Also Published As

Publication number Publication date
IL147666A0 (en) 2002-08-14
CZ2002190A3 (cs) 2003-08-13
TR200200622T2 (cs) 2002-06-21
EP1196394A1 (de) 2002-04-17
CA2379545A1 (en) 2001-01-25
AR030026A1 (es) 2003-08-13
DE19933164A1 (de) 2001-01-25
HUP0202646A2 (hu) 2003-02-28
PL353165A1 (en) 2003-10-20
NO20020254D0 (no) 2002-01-17
CN1367778A (zh) 2002-09-04
AU6561500A (en) 2001-02-05
HUP0202646A3 (en) 2003-03-28
BG106321A (en) 2002-08-30
TW555749B (en) 2003-10-01
MXPA02000616A (es) 2002-08-30
BR0012592A (pt) 2002-05-28
ZA200200333B (en) 2003-04-30
SK772002A3 (en) 2003-01-09
KR20020019550A (ko) 2002-03-12
WO2001005771A1 (de) 2001-01-25
JP2003505377A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
EP1349839B8 (en) Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
LTC1035115I2 (lt) 4-Fenilpiridino dariniai ir jų, kaip NK-1 receptoriaus antagonistų, panaudojimas
NO20014098D0 (no) 3-fenylpyridinderivater og anvendelse derav som NK-1 reseptor antagonister
NO991079L (no) Azinyloksy- og fenoksy-diaryl-karboksylsyre-derivater, deres fremstilling og deres anvendelse som blandede ETA/ETB-endotelin-reseptor-antagonister
NO20002124D0 (no) Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister
NO992976L (no) Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister
NO20014224L (no) 4-heterocyklysulfonamidyl-6-metoksy-5-(2-metoksy-fenoksy)-2- pyridyl-pyrimidinderivater, fremstilling derav og anvendelse somendotelin reseptor antagonister
NO20020254L (no) Nye karboksylsyrederivater med 5,6-substituert pyrimidinring, fremstilling og anvendelse derav som endotelinreseptor-antagonister
NO996268D0 (no) Nye <beta>-amino- og <beta>-azidokarboksylsyrederivater, fremstilling derav og anvendelse derav som endothelinreseptorantagonister
NO20001077D0 (no) Nye karboksylsyrederivater, deres fremstilling og anvendelse som blandete ETA/ETB-endothelin-reseptorantagonister
PL375263A1 (en) 2,5-substituted pyrimidine derivatives as ccr-3 receptor antagonists
NO20010622D0 (no) Nye karboksylsyrederivater som bærer keto-sidekjeder, deres fremstilling og deres anvendelse som endotelinreseptor- antagonister
IL143451A0 (en) NEW- β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
NO20040426L (no) Nye imidazolidinderivater og deres fremstilling og andvendelse som VLA-4-antagonister.
ZA9810425B (en) Novel heterocyclically substituted Ó-hydroxycarboxylic acid derivatives, their preparation and use as endothelin receptor antagonists.
IL146800A0 (en) Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their preparation and use as endothelin receptor antagonists
AU2001231744A1 (en) Novel carboxylic acid derivatives containing alkyl substituted triazines, production of the same and use thereof as endothelin receptor antagonists
ZA991738B (en) Novel unsymmetrically substituted carboxylic acid derivatives, their preparation and use as mixed et /et receptor antagonists.
ZA988053B (en) Novel carboxylic acid derivatives, their preparation and use as mixed ETA/ETB receptor antagonists.
ZA9711305B (en) Heterocyclic carboxylic acid derivatives their preparation and use as endothelin receptor antagonists
ZA989923B (en) Novel carboxylic acid derivatives with amide side chains, their preparation and use as endothelin receptor antagonists.
DK1200402T3 (da) Substituerede 1,5-dihydropyrrol-2-on-derivater med virkning som NMDA-receptorantagonister til behandling af smertetilstande

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application